Olaparib shows promising results against inherited forms of breast and ovarian cancer

[News]

Olaparib, a new type of experimental drug called a PARP inhibitor, has shown promising results against inherited forms of breast and ovarian cancer in two small clinical trials led by scientists at the Breakthrough Breast Cancer Research Unit at King's College London.

More... (http://www.news-medical.net/news/20100708/Olaparib-shows-promising-results-against-inherited-forms-of-breast-and-ovarian-cancer.aspx)